Perform systematic literature review on photobiomodulation (PBM) devices used at home for nonesthetic applications.
Background:
Home-use PBM devices have been marketed for cosmetic and therapeutic purposes. This is the first systematic literature review for nonesthetic applications.
Methods:
A systematic literature search was conducted for PBM devices self-applied at home at least thrice a week. Two independent reviewers screened the articles and extracted the data. Treatment dosage appropriateness was compared to the World Association for Laser Therapy (WALT) recommendations. The efficacy was evaluated according to the relevant primary end-point for the specific indication.
Results:
Eleven studies were suitable. Devices were applied for a range of indications, including pain, cognitive dysfunction, wound healing, diabetic macular edema, and postprocedural side effects, and were mostly based on near-infrared, pulsed light-emitting diodes with dosages within WALT recommendations. Regarding efficacy, studies reported mostly positive results.
Conclusions:
Home-use PBM devices appear to mediate effective, safe treatments in a variety of conditions that require frequent applications. Conclusive evaluation of their efficacy requires additional, randomized controlled studies.
Get full access to this article
View all access options for this article.
References
1.
ChungH, DaiT, SharmaSK, HuangYY, CarrollJD, HamblinMR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng, 2012; 40:516–533.
2.
TunerJ.PhotoBioModulation: how many sessions and how often?. Photomed Laser Surg, 2018; 36:59–60.
3.
MunS, ParkJH, BaekSM, LeeM, ChoiSM, LeeS. Self-care use patterns in the UK, US, Australia, and Japan: a multinational web-based survey. Integr Med Res, 2016; 5:151–160.
4.
Centers for Disease Control and Prevention. Chronic Disease Self-Management Program (CDSMP). 2016. Available at: https://www.cdc.gov/arthritis/marketing-support/1-2-3-approach/docs/pdf/provider_fact_sheet_cdsmp.pdf (Last accessed October2018).
5.
RennerA-T, BobekJ, OstermannH, SchneiderP, VoglerS. A cost/benefit analysis of self-care initiatives in the European Union: who gains, who loses?. J Pharm Policy Pract, 2015; 8:O5.
6.
LandersSH.Why health care is going home. N Engl J Med, 2010; 363:1690–1691.
7.
DoddEM, WinterMA, HordinskyMK, SadickNS, FarahRS. Photobiomodulation therapy for androgenetic alopecia: a clinician's guide to home-use devices cleared by the Federal Drug Administration. J Cosmet Laser Ther, 2018; 20:159–167.
8.
JuhaszML, LevinMK, MarmurES. A review of available laser and intense light source home devices: a dermatologist's perspective. J Cosmet Dermatol, 2017; 16:438–443.
9.
HessionMT, MarkovaA, GraberEM. A review of hand-held, home-use cosmetic laser and light devices. Dermatol Surg, 2015; 41:307–320.
10.
FornainiC, PelosiA, QueiroloV, VescoviP, MerigoE. The “at-home LLLT” in temporo-mandibular disorders pain control: a pilot study. Laser Ther, 2015; 24:47–52.
11.
MerigoE, RoccaJP, OppiciA, CellaL, FornainiC. At-home laser treatment of oral neuronal disorders: case reports. J Clin Exp Dent, 2017; 9:e595–e598.
12.
SaltmarcheAE, NaeserMA, HoKF, HamblinMR, LimL. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report. Photomed Laser Surg, 2017; 35:432–441.
13.
WALT. World Association for Laser Therapy: Recommended Treatment Doses for Low Level Laser Therapy. 2010. Available at: http://waltzacoza/wp-content/uploads/2012/08/Dose_table_780-860nm_for_Low_Level_Laser_Therapy_WALT-2010.pdf (Last accessed October2018).
14.
MoherD, ShamseerL, ClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 2015; 4:1.
15.
LiberatiA, AltmanDG, TetzlaffJ, et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 2009; 339:b2700.
16.
StelianJ, GilI, HabotB, et al.Improvement of pain and disability in elderly patients with degenerative osteoarthritis of the knee treated with narrow-band light therapy. J Am Geriatr Soc, 1992; 40:23–26.
17.
TangJ, HerdaAA, KernTS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol, 2014; 98:1013–1015.
18.
LaveryLA, MurdochDP, WilliamsJ, LaveryDC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care, 2008; 31:316–321.
19.
NaeserMA, SaltmarcheA, KrengelMH, HamblinMR, KnightJA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg, 2011; 29:351–358.
20.
HargateG.A randomised double-blind study comparing the effect of 1072-nm light against placebo for the treatment of herpes labialis. Clin Exp Dermatol, 2006; 31:638–641.
21.
NatherA, SimYE, ChewL, NeoSH. Anodyne therapy for recalcitrant diabetic foot ulcers: a report of four cases. J Orthop Surg (Hong Kong), 2007; 15:361–364.
22.
BaroletD, BoucherA. Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series. Lasers Surg Med, 2010; 42:597–601.
23.
BaroletD, YaroslavskyI, CohenR. Accelerating wound healing recovery by LLLT therapy after an ablative fractional resurfacing procedure. Lasers Surg Med, 2009; 41:28–29.
24.
HazehA, ElishoovO, ShorkaD, TsoharT, LiebergalM.Abstract: Healing of chronic diabetic foot ulcers using low level laser therapy (B-Cure laser). In: The 37th Annual Meeting of the Israel Orthopaedic Association. Tel-Aviv, Israel, 2017.
25.
Del VecchioA, FioravantiM, BoccassiniA, Di PaoloC, RomeoU.Abstract: A new home protocol of LLLT in patients affected by TMJD related pain: results of a randomized, double blind, placebo controlled clinical trial. In: The 15th Congress of the World Federation for Laser Dentistry. Nagoya, Japan, 2016.
26.
GooBL, KimDY, KwonJY. Abstract: Clinical efficacy of low level light home device for the symptoms of the menorrhagia: a pilot study. In: The 36th Annual Conference of the American Society for Laser Medicine and Surgery. Boston, MA, 2016.
JenkinsPA, CarrollJD. How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies. Photomed Laser Surg, 2011; 29:785–787.
BjordalJM, CouppeC, ChowRT, TunerJ, LjunggrenEA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother, 2003; 49:107–116.
31.
GavishL.Chapter 50: Low-level laser therapy for wound healing. In: Handbook of Photomedicine. HamblinM, HuangY (eds.). Boca Raton: CRC Press, 2013.
32.
Munoz SanchezPJ, Capote FemeniasJL, Diaz TejedaA, TunerJ. The effect of 670-nm low laser therapy on herpes simplex type 1. Photomed Laser Surg, 2012; 30:37–40.
33.
de CarvalhoRR, de Paula EduardoF, RamalhoKM, et al.Effect of laser phototherapy on recurring herpes labialis prevention: an in vivo study. Lasers Med Sci, 2010; 25:397–402.
34.
SchindlA, NeumannR. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J Invest Dermatol, 1999; 113:221–223.
35.
WhinfieldAL, AitkenheadI. The light revival: does phototherapy promote wound healing? A review. Foot (Edinb), 2009; 19:117–124.
36.
CarvalhoRL, AlcantaraPS, KamamotoF, CressoniMD, CasarottoRA. Effects of low-level laser therapy on pain and scar formation after inguinal herniation surgery: a randomized controlled single-blind study. Photomed Laser Surg, 2010; 28:417–422.
37.
KhouryJG, GoldmanMP. Use of light-emitting diode photomodulation to reduce erythema and discomfort after intense pulsed light treatment of photodamage. J Cosmet Dermatol, 2008; 7:30–34.
38.
CalderheadRG, KimWS, OhshiroT, TrellesMA, VasilyDB. Adjunctive 830 nm light-emitting diode therapy can improve the results following aesthetic procedures. Laser Ther, 2015; 24:277–289.
39.
OzenT, OrhanK, GorurI, OzturkA. Efficacy of low level laser therapy on neurosensory recovery after injury to the inferior alveolar nerve. Head Face Med, 2006; 2:3.
40.
KhullarSM, BrodinP, BarkvollP, HaanaesHR. Preliminary study of low-level laser for treatment of long-standing sensory aberrations in the inferior alveolar nerve. J Oral Maxillofac Surg, 1996; 54:2–7; discussion 7–8.
41.
PowellMW, CarnegieDH, BurkeTJ. Reversal of diabetic peripheral neuropathy with phototherapy (MIRE) decreases falls and the fear of falling and improves activities of daily living in seniors. Age Ageing, 2006; 35:11–16.
42.
GenevaII.Photobiomodulation for the treatment of retinal diseases: a review. Int J Ophthalmol, 2016; 9:145–152.
43.
ChengY, DuY, LiuH, TangJ, VeenstraA, KernTS. Photobiomodulation inhibits long-term structural and functional lesions of diabetic retinopathy. Diabetes, 2018; 67:291–298.
44.
MerryGF, MunkMR, DotsonRS, WalkerMG, DevenyiRG. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration. Acta Ophthalmol, 2017; 95:e270–e277.
45.
HashmiJT, HuangYY, SharmaSK, et al.Effect of pulsing in low-level light therapy. Lasers Surg Med, 2010; 42:450–466.
46.
PogodaevAA, WongASY, HuckWTS. Photochemical control over oscillations in chemical reaction networks. J Am Chem Soc, 2017; 139:15296–15299.
47.
BaroletD, DuplayP, JacomyH, AuclairM. Importance of pulsing illumination parameters in low-level-light therapy. J Biomed Opt, 2010; 15:048005.
SommerAP.Aging is a sticky business. Photomed Laser Surg, 2018; 36:284–286.
50.
CassanoP, PetrieS, MischoulonD, et al.Transcranial photobiomodulation for the treatment of major depressive disorder: the ELATED-2 clinical trial. Neuropsychopharmacology, 2016; 41:S354–S355.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
